Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Thermally driven bubble evolution at a heater wire in water characterized by high-speed transmission electron microscopy.

Vance JR, Dillon SJ.

Chem Commun (Camb). 2017 May 2;53(36):4930-4933. doi: 10.1039/c7cc00964j.

PMID:
28338698
2.

Large-deformation and high-strength amorphous porous carbon nanospheres.

Yang W, Mao S, Yang J, Shang T, Song H, Mabon J, Swiech W, Vance JR, Yue Z, Dillon SJ, Xu H, Xu B.

Sci Rep. 2016 Apr 13;6:24187. doi: 10.1038/srep24187.

3.

Iron-catalyzed dehydropolymerization: a convenient route to poly(phosphinoboranes) with molecular-weight control.

Schäfer A, Jurca T, Turner J, Vance JR, Lee K, Du VA, Haddow MF, Whittell GR, Manners I.

Angew Chem Int Ed Engl. 2015 Apr 13;54(16):4836-41. doi: 10.1002/anie.201411957. Epub 2015 Feb 25.

PMID:
25712707
4.

Iron-catalyzed dehydrocoupling/dehydrogenation of amine-boranes.

Vance JR, Schäfer A, Robertson AP, Lee K, Turner J, Whittell GR, Manners I.

J Am Chem Soc. 2014 Feb 26;136(8):3048-64. doi: 10.1021/ja410129j. Epub 2014 Feb 14.

PMID:
24527706
5.

Paramagnetic titanium(III) and zirconium(III) metallocene complexes as precatalysts for the dehydrocoupling/dehydrogenation of amine-boranes.

Helten H, Dutta B, Vance JR, Sloan ME, Haddow MF, Sproules S, Collison D, Whittell GR, Lloyd-Jones GC, Manners I.

Angew Chem Int Ed Engl. 2013 Jan 2;52(1):437-40. doi: 10.1002/anie.201207903. Epub 2012 Nov 29.

PMID:
23197391
6.

"Spontaneous" ambient temperature dehydrocoupling of aromatic amine-boranes.

Helten H, Robertson AP, Staubitz A, Vance JR, Haddow MF, Manners I.

Chemistry. 2012 Apr 10;18(15):4665-80. doi: 10.1002/chem.201103241. Epub 2012 Mar 5.

PMID:
22392879
7.

Photoactivated, iron-catalyzed dehydrocoupling of amine-borane adducts: formation of boron-nitrogen oligomers and polymers.

Vance JR, Robertson AP, Lee K, Manners I.

Chemistry. 2011 Apr 4;17(15):4099-103. doi: 10.1002/chem.201003397. Epub 2011 Mar 8. No abstract available.

PMID:
21387434
8.

Substitution of conserved residues within the active site alters the cleavage religation equilibrium of DNA topoisomerase I.

Colley WC, van der Merwe M, Vance JR, Burgin AB Jr, Bjornsti MA.

J Biol Chem. 2004 Dec 24;279(52):54069-78. Epub 2004 Oct 15.

9.

Antitumor agents. 234. Design, synthesis, and biological evaluation of novel 4beta-[(4' '-benzamido)-amino]-4'-o-demethyl-epipodophyllotoxin derivatives.

Xiao Z, Bastow KF, Vance JR, Sidwell RS, Wang HK, Chen MS, Shi Q, Lee KH.

J Med Chem. 2004 Oct 7;47(21):5140-8.

PMID:
15456257
10.

Antitumor agents. Part 235: Novel 4'-ester etoposide analogues as potent DNA topoisomerase II inhibitors with improved therapeutic potential.

Xiao Z, Vance JR, Bastow KF, Brossi A, Wang HK, Lee KH.

Bioorg Med Chem. 2004 Jun 15;12(12):3363-9.

PMID:
15158805
11.

Antitumor agents. Part 227: Studies on novel 4'-O-demethyl-epipodophyllotoxins as antitumor agents targeting topoisomerase II.

Xiao Z, Bastow KF, Vance JR, Lee KH.

Bioorg Med Chem. 2004 Jun 15;12(12):3339-44.

PMID:
15158802
12.

The role of yeast DNA 3'-phosphatase Tpp1 and rad1/Rad10 endonuclease in processing spontaneous and induced base lesions.

Karumbati AS, Deshpande RA, Jilani A, Vance JR, Ramotar D, Wilson TE.

J Biol Chem. 2003 Aug 15;278(33):31434-43. Epub 2003 Jun 3.

13.

Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage.

Vance JR, Wilson TE.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13669-74. Epub 2002 Oct 4.

14.

Active site mutations in DNA topoisomerase I distinguish the cytotoxic activities of camptothecin and the indolocarbazole, rebeccamycin.

Woo MH, Vance JR, Marcos AR, Bailly C, Bjornsti MA.

J Biol Chem. 2002 Feb 8;277(6):3813-22. Epub 2001 Dec 3.

16.
17.

Studying DNA topoisomerase I-targeted drugs in the yeast. Saccharomyces cerevisiae.

Woo MH, Vance JR, Bjornsti MA.

Methods Mol Biol. 2001;95:303-13. No abstract available.

PMID:
11089242
18.
20.

The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-4N-substituted thiosemicarbazones.

Miller MC 3rd, Stineman CN, Vance JR, West DX, Hall IH.

Anticancer Res. 1998 Nov-Dec;18(6A):4131-9.

PMID:
9891458
21.

The cytotoxicity of 2-formyl and 2-acetyl-(6-picolyl)-4N-substituted thiosemicarbazones and their copper(II) complexes.

Miller MC 3rd, Bastow KF, Stineman CN, Vance JR, Song SC, West DX, Hall IH.

Arch Pharm (Weinheim). 1998 Apr;331(4):121-7.

PMID:
9648520
22.

In vivo accuracy of gravity-flow i.v. infusion systems.

Crass RE, Vance JR.

Am J Hosp Pharm. 1985 Feb;42(2):328-31.

PMID:
3976679
23.

Furosemide-associated ototoxicity.

DeVito JM, Vance JR.

Clin Pharm. 1983 Nov-Dec;2(6):507-8. No abstract available.

PMID:
6653051
24.

Central visual field contributions to the visual-evoked response.

Vance JR, Jones R.

Am J Optom Physiol Opt. 1980 Apr;57(4):197-204.

PMID:
7386580

Supplemental Content

Loading ...
Support Center